Asosiy kontentga oʻtish
Sharh maqola

The therapeutic effects and mechanisms of action of baicalin in sepsis: a systematic review

Usamah SayedFaculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman UniversityNaji Musa AliDepartment of Pharmacy, College of Pharmacy, The Islamic UniversityS. Renuka JyothiDepartment of Biotechnology and Genetics, School of Sciences, JAIN (Deemed to be University)Ritesh SinghDepartment of Pharmacy, Sharda School of Pharmacy, Sharda UniversityNeeraj BainsalUniversity Institute of Pharma Sciences, Chandigarh UniversityJasur RizaevDepartment of Public Health and Healthcare Management, Rector, Samarkand State Medical UniversityInoyatillo KholmurodovDepartment of Basic Medical Sciences, Termez University of Economics and Service
2026en

Ochiq kirish: yoʻq

ABI

Annotatsiya

Sepsis is a critical medical state considered a life-threatening response to infection, leading to extensive inflammation and potential organ dysfunction. This systematic review focuses on the therapeutic impact of baicalin on sepsis complications. Methods: This systematic review followed PRISMA guidelines and was registered in PROSPERO. We searched PubMed, Web of Science, Scopus, Embase, and Google Scholar up to May 10, 2026. We included in vitro and in vivo experimental studies of baicalin in sepsis-related models. Results: Of 669 records, 41 studies met the eligibility criteria. Baicalin consistently reduced oxidative stress markers, pro-inflammatory cytokines, and activation of NF-κB, TLR4, HMGB1, and NLRP3-related pathways, while increasing antioxidant and anti-inflammatory mediators. Several studies also reported improved organ protection and survival. Conclusions: Baicalin appears beneficial in preclinical sepsis models, but evidence certainty is limited by heterogeneity, a lack of human studies, and the absence of a meta-analysis.

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar